Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 53635D202 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Paul B Manning
13G/A
Amendment 5
|
6.5% |
8/14/2026
Event 6/30/2026
|
|
| Paul B Manning | 6.5% | ||
| PD Joint Holdings, LLC Series 2016-A | 0.2% | ||
| BKB Growth Investments, LLC | 0.8% | ||
|
Farallon Capital Management, L.L.C.
13G/A
Amendment 3
|
9.4% |
8/4/2026
Event 6/30/2026
|
|
| Farallon Capital Management, L.L.C. | 9.4% | ||
| Farallon Capital Partners, L.P. | 0% | ||
| Farallon Capital Institutional Partners, L.P. | 0% | ||
| Farallon Capital Institutional Partners II, L.P. | 0% | ||
| Farallon Capital Institutional Partners III, L.P. | 0% | ||
| Four Crossings Institutional Partners V, L.P. | 0% | ||
| Farallon Capital Offshore Investors II, L.P. | 0% | ||
| Farallon Capital (AM) Investors, L.P. | 0% | ||
| Farallon Capital F5 Master I, L.P. | 0% | ||
| Farallon Healthcare Partners Master, L.P. | 0% | ||
| Farallon Partners, L.L.C. | 0% | ||
| Farallon Institutional (GP) V, L.L.C. | 0% | ||
| Farallon F5 (GP), L.L.C. | 0% | ||
| Farallon Healthcare Partners (GP), L.L.C. | 0% | ||
| Dapice Joshua J. | 9.4% | ||
| Dreyfuss, Philip D. | 9.4% | ||
| Dunn Hannah E. | 9.4% | ||
| Gehani, Varun N. | 9.4% | ||
| Giauque, Nicolas | 9.4% | ||
| Husen, Avner A. | 9.4% | ||
| Kim, David T. | 9.4% | ||
| Linn, Michael G. | 9.4% | ||
| Luo Patrick (Cheng) | 9.4% | ||
| Roberts, Jr., Thomas G. | 9.4% | ||
| Saito Edric C. | 9.4% | ||
| Short Daniel S. | 9.4% | ||
| Spokes, Andrew J. M. | 9.4% | ||
| Warren, John R. | 9.4% | ||
| Wehrly, Mark C. | 9.4% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 11.9% |
7/8/2026
Event 6/30/2026
|
|
|
Farallon Capital Partners, L.P.
13G/A
Amendment 2
|
9.9% |
2/9/2026
Event 12/31/2025
|
|
| Farallon Capital Partners, L.P. | 0.8% | ||
| Farallon Capital Institutional Partners, L.P. | 0.7% | ||
| Farallon Capital Institutional Partners II, L.P. | 0.3% | ||
| Farallon Capital Institutional Partners III, L.P. | 0.2% | ||
| Four Crossings Institutional Partners V, L.P. | 0.2% | ||
| Farallon Capital Offshore Investors II, L.P. | 1.8% | ||
| Farallon Capital F5 Master I, L.P. | 0.2% | ||
| Farallon Capital (AM) Investors, L.P. | 0.1% | ||
| Farallon Healthcare Partners Master, L.P. | 5.7% | ||
| Farallon Partners, L.L.C. | 9.7% | ||
| Farallon Institutional (GP) V, L.L.C. | 0.2% | ||
| Farallon F5 (GP), L.L.C. | 0.2% | ||
| Farallon Healthcare Partners (GP), L.L.C. | 5.7% | ||
| Dapice Joshua J. | 9.9% | ||
| Dreyfuss, Philip D. | 9.9% | ||
| Dunn Hannah E. | 9.9% | ||
| Fried, Richard B | 0% | ||
| Gehani, Varun N. | 9.9% | ||
| Giauque, Nicolas | 9.9% | ||
| Husen, Avner A. | 9.9% | ||
| Kim, David T. | 9.9% | ||
| Linn, Michael G. | 9.9% | ||
| Luo Patrick (Cheng) | 9.9% | ||
| Patel, Rajiv A. | 0% | ||
| Roberts, Jr., Thomas G. | 9.9% | ||
| Saito Edric C. | 9.9% | ||
| Seybold, William | 0% | ||
| Short Daniel S. | 9.9% | ||
| Spokes, Andrew J. M. | 9.9% | ||
| Warren, John R. | 9.9% | ||
| Wehrly, Mark C. | 9.9% | ||
|
Farallon Capital Partners, L.P.
13G/A
Amendment 1
|
10.0% |
11/12/2025
Event 9/30/2025
|
|
| Farallon Capital Partners, L.P. | 0.9% | ||
| Farallon Capital Institutional Partners, L.P. | 0.8% | ||
| Farallon Capital Institutional Partners II, L.P. | 0.3% | ||
| Farallon Capital Institutional Partners III, L.P. | 0.2% | ||
| Four Crossings Institutional Partners V, L.P. | 0.2% | ||
| Farallon Capital Offshore Investors II, L.P. | 1.9% | ||
| Farallon Capital F5 Master I, L.P. | 0.2% | ||
| Farallon Capital (AM) Investors, L.P. | 0.1% | ||
| Farallon Healthcare Partners Master, L.P. | 5.3% | ||
| Farallon Partners, L.L.C. | 9.7% | ||
| Farallon Institutional (GP) V, L.L.C. | 0.2% | ||
| Farallon F5 (GP), L.L.C. | 0.2% | ||
| Farallon Healthcare Partners (GP), L.L.C. | 5.3% | ||
| Dapice Joshua J. | 10.0% | ||
| Dreyfuss, Philip D. | 10.0% | ||
| Dunn Hannah E. | 10.0% | ||
| Fried, Richard B | 10.0% | ||
| Gehani, Varun N. | 10.0% | ||
| Giauque, Nicolas | 10.0% | ||
| Kim, David T. | 10.0% | ||
| Linn, Michael G. | 10.0% | ||
| Luo Patrick (Cheng) | 10.0% | ||
| Patel, Rajiv A. | 10.0% | ||
| Roberts, Jr., Thomas G. | 10.0% | ||
| Saito Edric C. | 10.0% | ||
| Seybold, William | 10.0% | ||
| Short Daniel S. | 10.0% | ||
| Spokes, Andrew J. M. | 10.0% | ||
| Warren, John R. | 10.0% | ||
| Wehrly, Mark C. | 10.0% | ||
|
Farallon Capital Partners, L.P.
13G
|
8.0% |
7/11/2025
Event 7/7/2025
|
|
| Farallon Capital Partners, L.P. | 0.9% | ||
| Farallon Capital Institutional Partners, L.P. | 0.8% | ||
| Farallon Capital Institutional Partners II, L.P. | 0.3% | ||
| Farallon Capital Institutional Partners III, L.P. | 0.2% | ||
| Four Crossings Institutional Partners V, L.P. | 0.2% | ||
| Farallon Capital Offshore Investors II, L.P. | 2.0% | ||
| Farallon Capital F5 Master I, L.P. | 0.2% | ||
| Farallon Capital (AM) Investors, L.P. | 0.1% | ||
| Farallon Healthcare Partners Master, L.P. | 3.0% | ||
| Farallon Partners, L.L.C. | 7.7% | ||
| Farallon Institutional (GP) V, L.L.C. | 0.2% | ||
| Farallon F5 (GP), L.L.C. | 0.2% | ||
| Farallon Healthcare Partners (GP), L.L.C. | 3.0% | ||
| Dapice Joshua J. | 8.0% | ||
| Dreyfuss, Philip D. | 8.0% | ||
| Dunn Hannah E. | 8.0% | ||
| Fried, Richard B | 8.0% | ||
| Gehani, Varun N. | 8.0% | ||
| Giauque, Nicolas | 8.0% | ||
| Kim, David T. | 8.0% | ||
| Linn, Michael G. | 8.0% | ||
| Luo Patrick (Cheng) | 8.0% | ||
| Patel, Rajiv A. | 8.0% | ||
| Roberts, Jr., Thomas G. | 8.0% | ||
| Saito Edric C. | 8.0% | ||
| Seybold, William | 8.0% | ||
| Short Daniel S. | 8.0% | ||
| Spokes, Andrew J. M. | 8.0% | ||
| Warren, John R. | 8.0% | ||
| Wehrly, Mark C. | 8.0% | ||
|
Legend Aggregator, LP
13G/A
Amendment 1
|
2.2% |
2/12/2025
Event 12/31/2024
|
|
| Legend Aggregator, LP | 2.2% | ||
| Legend Aggregator Advisors, LLC | 2.2% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 45 | 970 k | $30.4 M |
| 2026 Q2 | 368 | 78.5 M | $5.86 B |
| 2026 Q1 | 281 | 61.6 M | $2.32 B |
| 2025 Q4 | 260 | 61.9 M | $2.13 B |
| 2025 Q3 | 235 | 64.6 M | $1.48 B |
| 2025 Q2 | 206 | 57.7 M | $720 M |
| 2025 Q1 | 187 | 55.3 M | $816 M |
| 2024 Q4 | 187 | 51.5 M | $626 M |
| 2024 Q3 | 172 | 52.9 M | $528 M |
| 2024 Q2 | 165 | 47.0 M | $564 M |
| 2024 Q1 | 163 | 47.6 M | $702 M |
| 2023 Q4 | 142 | 37.2 M | $447 M |
| 2023 Q3 | 117 | 28.6 M | $185 M |
| 2023 Q2 | 113 | 29.1 M | $229 M |
| 2023 Q1 | 101 | 29.5 M | $207 M |
| 2022 Q4 | 100 | 32.2 M | $211 M |
| 2022 Q3 | 109 | 21.1 M | $115 M |
| 2022 Q2 | 88 | 23.0 M | $100 M |
| 2022 Q1 | 69 | 14.1 M | $101 M |
| 2021 Q4 | 52 | 10.7 M | $52.2 M |
| 2021 Q3 | 45 | 10.3 M | $28.5 M |
| 2021 Q2 | 58 | 10.6 M | $30.4 M |
| 2021 Q1 | 64 | 11.9 M | $32.0 M |
| 2020 Q4 | 63 | 11.1 M | $32.7 M |
| 2020 Q3 | 68 | 15.8 M | $77.9 M |
| 2020 Q2 | 80 | 20.1 M | $160 M |
| 2020 Q1 | 50 | 9.82 M | $46.3 M |
| 2019 Q4 | 52 | 13.2 M | $56.7 M |
| 2019 Q3 | 45 | 10.5 M | $37.4 M |
| 2019 Q2 | 46 | 11.0 M | $88.3 M |
| 2019 Q1 | 50 | 10.7 M | $121 M |
| 2018 Q4 | 35 | 7.37 M | $160 M |
| 2018 Q3 | 34 | 4.21 M | $116 M |